News & Analysis as of

Executive Orders Statutory Requirements

Goodwin

Year in Review: Top U.S. Biosimilars-Related Regulatory Developments of 2021

Goodwin on

As 2021 comes to a close, Big Molecule Watch reviews the top five biosimilar regulatory developments of the year... President Biden Signs Orange Book Transparency Act - In January, we reported that President Biden...more

Pullman & Comley, LLC

Order 7I

Pullman & Comley, LLC on

On March 21, 2020, Governor Lamont issued Executive Order No. 7I (the “Order”); Item No. 19, therein, modifies and/or suspends various procedural and statutory requirements regarding notice, commencement, and the holding of...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide